KBKatalina Biondi

Katalina Biondi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Katalina Biondi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Ana A. Weil

    Department of Medicine, University of Washington, Seattle, USA

    1 shared publication
  • Joshua D. Champlain

    Center for Emerging and Reemerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA

    1 shared publication
  • Kayode K. Ojo

    Department of Medicine, Center for Emerging and Re-Emerging Infectious Diseases, University of Washington, Seattle, WA 98109-4766, USA

    1 shared publication
  • Lyssa J. Weible

    Center for Emerging and Reemerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA

    1 shared publication
  • Mayuri Prabakaran

    Center for Emerging and Reemerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA

    1 shared publication
  • Ryan Ye Jiang

    Center for Emerging and Reemerging Infectious Diseases (CERID), Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA

    1 shared publication

Latest Publications

  • Open Access

    The Gut-Wrenching Effects of Cryptosporidiosis and Giardiasis in Children

    by Mayuri Prabakaran, Lyssa J. Weible, Joshua D. Champlain, Ryan Ye Jiang, Katalina Biondi, Ana A. Weil, Wesley C. Van Voorhis, Kayode K. Ojo

    Cryptosporidium species and Giardia duodenalis are infectious intestinal protozoan pathogens that cause alarming rates of morbidity and mortality worldwide. Children are more likely to have clinical symptoms due to their less developed immune systems and factors such as undernutrition, especially in low- and middle-income countries. The severity of the symptoms and clinical manifestations in children may vary from asymptomatic to life-threatening depending on the Cryptosporidium species/G. duodenalis strains and the resulting complex stepwise interactions between the parasite, the host nutritional and immunologic status, and the gut microbiome profile. Structural damages inflicted by both parasites to epithelial cells in the large and small intestines could severely impair children’s gut health, including the ability to absorb nutrients, resulting in stunted growth, diminished neurocognitive development, and other long-term effects. Clinically approved cryptosporidiosis and giardiasis drugs have broad antimicrobial effects that have incomprehensible impacts on growing children’s gut health.